Russell Investments Group
VKTX icon

Russell Investments Group’s Viking Therapeutics VKTX Stock Holding History

Russell Investments Group’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Buy
44,513
+13,021
+41% +$421K ﹤0.01% 2161
2026
Q1 		$1.02M Sell
31,492
-258
-0.8% -$8.29K ﹤0.01% 2199
2025
Q4 		$1.12M Buy
31,750
+102
+0.3% +$3.61K ﹤0.01% 2169
2025
Q3 		$832K Sell
31,648
-64,162
-67% -$1.91M ﹤0.01% 2277
2025
Q2 		$2.54M Sell
95,810
-2,224
-2% -$58.5K ﹤0.01% 1603
2025
Q1 		$2.37M Sell
98,034
-164,129
-63% -$5.19M ﹤0.01% 1588
2024
Q4 		$10.5M Sell
262,163
-143,854
-35% -$8.2M 0.01% 791
2024
Q3 		$25.7M Buy
406,017
+82,233
+25% +$4.82M 0.04% 489
2024
Q2 		$17.2M Sell
323,784
-21,041
-6% -$1.38M 0.03% 580
2024
Q1 		$28.3M Buy
344,825
+88,192
+34% +$3.92M 0.04% 441
2023
Q4 		$4.78M Buy
+256,633
New +$3.36M 0.01% 1149
2020
Q1 		– Sell
-19,312
Closed -$154K – 3151
2019
Q4 		$154K Hold
19,312
– – ﹤0.01% 2784
2019
Q3 		$133K Buy
+19,312
New +$143K ﹤0.01% 2756
2019
Q2 		– Sell
-312,051
Closed -$3.09M – 2961
2019
Q1 		$3.09M Sell
312,051
-10,262
-3% -$85.9K 0.01% 1498
2018
Q4 		$2.46M Buy
322,313
+64,431
+25% +$770K 0.01% 1500
2018
Q3 		$4.49M Buy
257,882
+172,572
+202% +$2.05M 0.01% 1358
2018
Q2 		$810K Buy
85,310
+75,635
+782% +$503K ﹤0.01% 2223
2018
Q1 		$42K Buy
+9,675
New +$53.5K ﹤0.01% 2836

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Russell Investments Group's VKTX Position: Q2 2026 in Review

Russell Investments Group increased its Viking Therapeutics (VKTX) stake by 41% in Q2 2026, buying an estimated $421K and bringing the position to 44,513 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2161.

Russell Investments Group first reported a position in VKTX in Q1 2018 and has held it in 18 quarters since. The position peaked at $28.3M in Q1 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Russell Investments Group held 44,513 shares of Viking Therapeutics worth $1.74M as of Q2 2026.
  • Russell Investments Group bought 13,021 Viking Therapeutics shares in Q2 2026, an estimated $421K.
  • Viking Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2161 holding.
  • Russell Investments Group first reported a position in Viking Therapeutics in Q1 2018 and has held it in 18 quarters since.
  • Russell Investments Group's Viking Therapeutics position peaked at $28.3M in Q1 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.